Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Muhammed Mustafa atci"'
Autor:
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 5 (2022)
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be preferred.
Externí odkaz:
https://doaj.org/article/76c42bc31695447ca49b70652deb5b62
Autor:
Abdullah Sakin, Suleyman Sahin, Muhammed Mustafa atci, Cumhur Demir, Nurgul Yasar, Caglayan Geredeli, Sener Cihan
Publikováno v:
Journal of Oncological Sciences, Vol 5, Iss 3, Pp 85-89 (2019)
Aim: The aim of this study was to evaluate the efficacy and tolerability of single-agent gemcitabine vs. capecitabine therapy in the second-line setting for metastatic Pancreatic Cancer (mPC) patients with poor performance status. Material and method
Externí odkaz:
https://doaj.org/article/78c8de41d70346d49662f865b955c5e8
Autor:
Pınar Gursoy, Ali Murat Tatli, Dilek Erdem, Erdem Goker, Emir Celik, Nebi Serkan Demirci, Abdullah Sakin, Muhammed Mustafa Atci, Ertuğrul Bayram, Tuğba Akın Telli, Burak Bilgin, Ahmet Bilici, Baran Akangunduz, Sevinç Balli, Ahmet Demirkazik, Fatih Selçukbiricik, Serkan Menekse, Eyyüp Cavdar, Akın Ozturk, Esma Türkmen Bekmez, Serdal Turhal, Sadettin Kilickap, Hasan Çağrı Yildirim, Başak Oyan, Asude Aksoy, Fatma Paksoy Turkoz, Engin Kut, Nuran Katgi, Teoman Sakalar, Murat Akyol, Halil İbrahim Ellez, Atakan Topcu, Atike Pınar Erdoğan, Kezban Nur Pilanci, Engin Hedem, Hacı Arak, Nadiye Akdeniz, Özkan Alan, Burcu Yapar, Deniz Nart, Perran Fulden Yumuk
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:865-875
Objectives: To compare the survival of first- and second-generation tyrosine kinase inhibitors (TKIs) in patients with rare EGFR exon 18 and exon 20 mutation-positive non-small cell lung cancer (NSCLC). Materials and methods: We retrospectively evalu
Autor:
Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir, Binnur Dönmez Yilmaz, Tugba Akin Telli, Orcun Can, Ibrahim Cil, Sabin Goktas Aydın, Neslihan Ozyurt, Arif Hakan Onder, Oguzhan Selvi, Abdullah Sakin
Publikováno v:
Oncology Research and Treatment. 45:254-261
Introduction: A significant proportion of cervical cancer (CC) patients are diagnosed at a locally advanced stage. Concurrent chemoradiotherapy (CCRT) is the cornerstone of treatment for patients with locally advanced CC. However, the role of adjuvan
Autor:
Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir, Rukiye Arikan, Seval Ay, Muhammet Ozer, Murat Ayhan, Ibrahim Cil, Nazan Demir, Neslihan Ozyurt, Gökhan Karakaya, Gokcen Tugba Cevik, Arif Hakan Onder, Oguzhan Selvi, Abdullah Sakin
The aim of this multicentre retrospective study was to compare the efficacy of adjuvant chemotherapy regimens both with and without oxaliplatin and tumor sidedness in stage IIB (pT4aN0) colon cancer patients. This study included patients with stage I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb53b257b4234927987052f53a720d9f
https://hdl.handle.net/11424/287169
https://hdl.handle.net/11424/287169
Initial albumin-bilirubin grade as a prognostic indicator of pancreatic cancer with liver metastasis
Autor:
Seval AY, Muhammed Mustafa ATCI, Rukiye ARIKAN, Özgecan DÜLGAR, Deniz TATAROĞLU ÖZYÜKSELER, Mahmut GÜMÜŞ
Objective: Pancreatic cancer (PCa) is the fourth leading cause of cancer-related deaths. Thus, there is a need for prognostic in-dicators that can aid in disease classification and subsequent selection of appropriate treatment options. Albumin-biliru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b027ba53287f95f3a5fb16ece9d012
https://hdl.handle.net/11424/289005
https://hdl.handle.net/11424/289005
Publikováno v:
Aktuelle Urologie. 53(6)
We aimed to show that the De Ritis Ratio (DRR) may be a new biomarker for lung metastasis in non-seminomatous Testicular Cancers (TC).Patients who underwent radical orchiectomy due to TC between January 2010 and January 2021 were included in the stud
Autor:
Yusuf Kemal Arslan, Eren Duzgun, Deniz Can Guven, Zeynep Altın, Muhammet Ozer, Fatih Ozcicek, Muhammed Mustafa Atci, İbrahim Çil, Azad Gunderci, Levent Demirtas, Baran Akagunduz
Publikováno v:
Supportive Care in Cancer. 29:7957-7964
Older cancer patients are more likely to present with functional dependency, multiple comorbidities, polypharmacy, malnutrition, and cognitive dysfunction than their younger counterparts which increases the risk of elder abuse. Herein, in this single
Autor:
Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici, Atakan Topcu, Musa Barış Aykan, Seda Kahraman, Ilgın Akbıyık, Muhammed Mustafa Atci, Omer Fatih Olmez, Arzu Yaren, Mehmet Ali Nahit Sendur, Caglayan Geredeli, Mesut Seker, Yuksel Urun, Nuri Karadurmus, Ahmet Aydin
Publikováno v:
Current medical research and opinion. 38(10)
Objectives: Advanced-stage biliary tract cancers (BTC) are rare malignancies with poor prognosis. There are few prospective trials, but several retrospective studies regarding treatment options. In this study, we aimed to investigate the role of syst
Autor:
Jamshid Hamdard, Abdullah Sakin, Serdar Arici, Ahmet Bilici, Tuba Saydam, Sener Cihan, Ruhper Cekin, Emin Kose, Selma Sengiz Erhan, Caglayan Geredeli, Burcu Saka, Muhammed Mustafa Atci
Publikováno v:
Colorectal Disease. 23:206-212
Aim The aim was to investigate theRASdiscordance between initial and recurrent metastasectomy specimens in metastatic colorectal cancer (mCRC) patients treated with chemotherapy (CT) plus biological agents in a first-line setting. Methods Patients wh